Status epilepticus: Difference between revisions
(Strip excess bold text - keep only critical safety emphasis) |
|||
| (41 intermediate revisions by 12 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Continuous seizure activity lasting >5 minutes, or ≥2 seizures without return to baseline<ref name="trinka">Trinka E, et al. A definition and classification of status epilepticus. Report of the ILAE Task Force. ''Epilepsia''. 2015;56(10):1515-1523. PMID 26336950.</ref> | |||
* | *'''Time-sensitive emergency''' — mortality increases with duration of seizure | ||
*30-day mortality: 20% overall; higher in elderly and those with anoxic injury | |||
* | *Refractory SE: seizures persisting despite two appropriate first-line agents | ||
** | *Super-refractory SE: seizures persisting >24 hours despite anesthetic agents | ||
* | |||
==Etiology== | |||
* | *Anti-epileptic drug (AED) non-compliance or subtherapeutic levels (most common in known epileptics) | ||
*Acute CNS injury: [[Stroke (main)|stroke]], [[Traumatic brain injury|TBI]], [[Meningitis|CNS infection]], tumor | |||
* | *Metabolic: [[Hypoglycemia|hypoglycemia]], [[Hyponatremia|hyponatremia]], [[Hypocalcemia|hypocalcemia]], hepatic failure, uremia | ||
*Toxicologic: [[Ethanol withdrawal|alcohol withdrawal]], [[Benzodiazepine withdrawal]], [[Isoniazid toxicity|INH]], [[Organophosphate toxicity|organophosphates]], [[Cocaine toxicity|cocaine]], [[Tricyclic antidepressant toxicity|TCA]] | |||
*** | *[[Eclampsia]] (pregnant/postpartum patients) | ||
*Febrile status epilepticus in children | |||
* | |||
==Clinical Features== | ==Clinical Features== | ||
*Generalized convulsive SE: continuous tonic-clonic activity, most readily recognized | |||
*Non-convulsive SE: subtle or no motor manifestations; persistent altered mental status | |||
**Must maintain high suspicion in patients who remain altered after apparent seizure cessation | |||
*Complications: [[Rhabdomyolysis|rhabdomyolysis]], [[Hyperthermia|hyperthermia]], lactic acidosis, aspiration, neuronal injury | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Seizure DDX}} | {{Seizure DDX}} | ||
== | ==Evaluation== | ||
*'''Bedside glucose''' — immediately | |||
*Labs: BMP (Na, Ca, Mg, glucose), CBC, AED levels, lactate, VBG, LFTs, toxicology screen | |||
*CT head — once stabilized; evaluate for structural cause | |||
*Continuous EEG — if available; essential to diagnose non-convulsive SE | |||
*LP if infection suspected (after CT and when safe) | |||
*CK, urinalysis (myoglobinuria) if prolonged seizure | |||
== | ==Management== | ||
===Time 0-5 min: Stabilize=== | |||
*ABCs, supplemental O2, cardiac monitor, IV access | |||
*'''Glucose''': check immediately; give '''D50W 50 mL IV''' (or D10W) if hypoglycemic | |||
*Thiamine 100 mg IV before glucose if malnourished or alcoholic | |||
*Position patient to prevent aspiration; suction as needed | |||
== | ===Time 5-20 min: First-Line — Benzodiazepines=== | ||
* | *'''[[Lorazepam]]''' 0.1 mg/kg IV (max 4 mg/dose), may repeat x1 in 5 min<ref name="silber">Silbergleit R, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. ''N Engl J Med''. 2012;366(7):591-600. PMID 22335736.</ref> | ||
*If no IV access: [[Midazolam]] 10 mg IM (most effective prehospital per RAMPART trial) | |||
*Alternatives: [[Diazepam]] 0.2 mg/kg IV (max 10 mg), or diazepam 20 mg PR | |||
* | |||
=== | ===Time 20-40 min: Second-Line — Anti-Epileptic Drug=== | ||
* | *'''[[Levetiracetam]]''' 60 mg/kg IV (max 4500 mg) over 15 min<ref name="kapur">Kapur J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (ESETT). ''N Engl J Med''. 2019;381(22):2103-2113. PMID 31774955.</ref> | ||
*[[Fosphenytoin]] 20 mg PE/kg IV (max rate 150 mg PE/min) | |||
*[[Valproic acid]] 40 mg/kg IV (max 3000 mg) over 10 min | |||
*ESETT trial: all three equally effective (~50% success each) | |||
* | |||
* | |||
* | |||
=== | ===Time >40 min: Refractory SE=== | ||
* | *'''[[Intubation (main)|Intubation]]''' and continuous infusion of anesthetic agent: | ||
* | **[[Midazolam]] 0.2 mg/kg IV bolus, then 0.1-2 mg/kg/hr | ||
* | **[[Propofol]] 2 mg/kg IV bolus, then 2-10 mg/kg/hr (monitor for propofol infusion syndrome) | ||
**[[Pentobarbital]] 5 mg/kg IV bolus, then 1-5 mg/kg/hr | |||
*Continuous EEG monitoring required | |||
*Target: burst-suppression for 24-48 hours | |||
**IV | |||
** | |||
** | |||
=== | ===Special Situations=== | ||
* | *[[Isoniazid toxicity|INH overdose]]: Pyridoxine (B6) gram-for-gram (empiric 5 g IV if dose unknown) | ||
*[[Eclampsia]]: Magnesium sulfate 4-6 g IV | |||
** | *[[Hyponatremia]]: Hypertonic saline (3%) 100 mL IV bolus | ||
==Disposition== | ==Disposition== | ||
* | *ICU admission for all SE patients | ||
*Neurology consultation | |||
*Patients with rapidly terminated seizures who return to baseline may be managed on a monitored floor | |||
==See Also== | ==See Also== | ||
*[[Seizure]] | *[[Seizure]] | ||
*[[First-time seizure]] | |||
*[[Eclampsia]] | |||
*[[Febrile seizure]] | |||
*[[Ethanol withdrawal]] | |||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category: | [[Category:Neurology]] | ||
Latest revision as of 09:23, 22 March 2026
Background
- Continuous seizure activity lasting >5 minutes, or ≥2 seizures without return to baseline[1]
- Time-sensitive emergency — mortality increases with duration of seizure
- 30-day mortality: 20% overall; higher in elderly and those with anoxic injury
- Refractory SE: seizures persisting despite two appropriate first-line agents
- Super-refractory SE: seizures persisting >24 hours despite anesthetic agents
Etiology
- Anti-epileptic drug (AED) non-compliance or subtherapeutic levels (most common in known epileptics)
- Acute CNS injury: stroke, TBI, CNS infection, tumor
- Metabolic: hypoglycemia, hyponatremia, hypocalcemia, hepatic failure, uremia
- Toxicologic: alcohol withdrawal, Benzodiazepine withdrawal, INH, organophosphates, cocaine, TCA
- Eclampsia (pregnant/postpartum patients)
- Febrile status epilepticus in children
Clinical Features
- Generalized convulsive SE: continuous tonic-clonic activity, most readily recognized
- Non-convulsive SE: subtle or no motor manifestations; persistent altered mental status
- Must maintain high suspicion in patients who remain altered after apparent seizure cessation
- Complications: rhabdomyolysis, hyperthermia, lactic acidosis, aspiration, neuronal injury
Differential Diagnosis
Seizure
- Epileptic seizure
- First-time seizure
- Seizure with known seizure disorder
- Status epilepticus
- Temporal lobe epilepsy
- Non-compliance with anti-epileptic medications
- Hyponatremia
- INH toxicity
- Non-epileptic seizure
- Meningitis
- Encephalitis
- Brain abscess
- Intracranial hemorrhage
- Alcohol withdrawal
- Benzodiazepine withdrawal
- Barbiturate withdrawal
- Baclofen withdrawal
- Metabolic abnormalities: hyponatremia, hypernatremia, hypocalcemia, hypomagnesemia, hypoglycemia, hyperglycemia, hepatic failure, uremia
- Eclampsia
- Neurocysticercosis
- Posterior reversible encephalopathy syndrome
- Impact seizure (head trauma)
- Acute hydrocephalus
- Arteriovenous malformation
- Seizure with VP shunt
- Toxic ingestion (amphetamines, anticholinergics, cocaine, INH, organophosphates, TCA, salicylates, lithium, phenothiazines, bupropion, camphor, clozapine, cyclosporine, fluoroquinolones, imipenem, lead, lidocaine, metronidazole, synthetic cannabinoids, theophylline, Starfruit)
- Psychogenic nonepileptic seizure (pseudoseizure)
- Intracranial mass
- Syncope
- Hyperventilation syndrome
- Migraine headache
- Movement disorders
- Narcolepsy/cataplexy
- Post-hypoxic myoclonus (Status myoclonicus)
Evaluation
- Bedside glucose — immediately
- Labs: BMP (Na, Ca, Mg, glucose), CBC, AED levels, lactate, VBG, LFTs, toxicology screen
- CT head — once stabilized; evaluate for structural cause
- Continuous EEG — if available; essential to diagnose non-convulsive SE
- LP if infection suspected (after CT and when safe)
- CK, urinalysis (myoglobinuria) if prolonged seizure
Management
Time 0-5 min: Stabilize
- ABCs, supplemental O2, cardiac monitor, IV access
- Glucose: check immediately; give D50W 50 mL IV (or D10W) if hypoglycemic
- Thiamine 100 mg IV before glucose if malnourished or alcoholic
- Position patient to prevent aspiration; suction as needed
Time 5-20 min: First-Line — Benzodiazepines
- Lorazepam 0.1 mg/kg IV (max 4 mg/dose), may repeat x1 in 5 min[2]
- If no IV access: Midazolam 10 mg IM (most effective prehospital per RAMPART trial)
- Alternatives: Diazepam 0.2 mg/kg IV (max 10 mg), or diazepam 20 mg PR
Time 20-40 min: Second-Line — Anti-Epileptic Drug
- Levetiracetam 60 mg/kg IV (max 4500 mg) over 15 min[3]
- Fosphenytoin 20 mg PE/kg IV (max rate 150 mg PE/min)
- Valproic acid 40 mg/kg IV (max 3000 mg) over 10 min
- ESETT trial: all three equally effective (~50% success each)
Time >40 min: Refractory SE
- Intubation and continuous infusion of anesthetic agent:
- Midazolam 0.2 mg/kg IV bolus, then 0.1-2 mg/kg/hr
- Propofol 2 mg/kg IV bolus, then 2-10 mg/kg/hr (monitor for propofol infusion syndrome)
- Pentobarbital 5 mg/kg IV bolus, then 1-5 mg/kg/hr
- Continuous EEG monitoring required
- Target: burst-suppression for 24-48 hours
Special Situations
- INH overdose: Pyridoxine (B6) gram-for-gram (empiric 5 g IV if dose unknown)
- Eclampsia: Magnesium sulfate 4-6 g IV
- Hyponatremia: Hypertonic saline (3%) 100 mL IV bolus
Disposition
- ICU admission for all SE patients
- Neurology consultation
- Patients with rapidly terminated seizures who return to baseline may be managed on a monitored floor
See Also
References
- ↑ Trinka E, et al. A definition and classification of status epilepticus. Report of the ILAE Task Force. Epilepsia. 2015;56(10):1515-1523. PMID 26336950.
- ↑ Silbergleit R, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366(7):591-600. PMID 22335736.
- ↑ Kapur J, et al. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus (ESETT). N Engl J Med. 2019;381(22):2103-2113. PMID 31774955.
